Oncobiologics
Why Robinhood?
You can watch Oncobiologics and buy or sell other stocks, ETFs, and their options commission-free!About ONS
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF.
ONS Key Statistics
Stock Snapshot
With a market cap of 18.53M, Oncobiologics(ONS) trades at $0.79. The stock has a price-to-earnings ratio of -0.20.
On 2026-04-03, Oncobiologics(ONS) stock opened at —, reached a high of —, and a low of —.
Oncobiologics(ONS) shares are trading with a volume of 0, against a daily average of 5.12M.
In the last year, Oncobiologics(ONS) shares hit a 52-week high of $3.39 and a 52-week low of $0.16.
In the last year, Oncobiologics(ONS) shares hit a 52-week high of $3.39 and a 52-week low of $0.16.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.